Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMICUS THERAPEUTICS, INC. Director's Dealing 2012

Aug 30, 2012

31523_dirs_2012-08-30_cbc200ac-fbe2-4b20-94a9-119cd1276986.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-08-29

Reporting Person: Winterbottom Joan (SVP, Human Resources)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-29 Stock Options (right to buy) $5.01 A 125000 Disposed 2022-08-29 Common Stock (125000) Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on August 29, 2013. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on September 1, 2013, with the final installment vesting on August 29, 2016.